Get started

Financials · DH

Definitive Healthcare Corp. (DH) financials

For the twelve months ended Sep 30, 2026, Definitive Healthcare Corp. reported $227.31M of revenue and -$213.01M of net income.

Revenue, TTM
$227.31M
Revenue growth, YoY
-6.2%
Net income, TTM
-$213.01M
Net margin
-93.7%
Free cash flow, TTM
$24.19M
EPS, diluted, TTM
-$1.55
Cash
$177.14M
Total debt
$158.53M
P/S
0.72
Market cap
$163.0M
Annual revenue$241.52M
FY2020FY2025
Annual net income-$138.93M
FY2020FY2025
Annual free cash flow$37.06M
FY2020FY2025

DH revenue and earnings growth

DH revenueQ3 2026$54.65M

Quarter YoY
-9.0%
QoQ
-1.0%
FY YoY
-4.2%
5Y CAGR
+15.3%

DH revenue was $54.65M in fiscal Q3 2026 (ended Sep 30, 2026), down 9.0% from a year earlier and down 1.0% from the prior quarter. For the full fiscal 2025 it was $241.52M, down 4.2% from fiscal 2024. Compound annual growth was +15.3% over 5 years. It rose in 4 of the last 5 fiscal years.

DH net incomeQ3 2026-$3.89M

DH net income was -$3.89M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$14.84M a year earlier. For the full fiscal 2025 it was -$138.93M, compared with -$413.12M in fiscal 2024.

DH EPSQ3 2026-$0.04

DH diluted EPS was -$0.04 in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$0.14 a year earlier. For the full fiscal 2025 it was -$1.30, compared with -$3.54 in fiscal 2024.

DH free cash flowQ3 2026$9.04M

Quarter YoY
-32.6%
QoQ
+6.1%
FY YoY
-19.2%
5Y CAGR
+11.2%

DH free cash flow was $9.04M in fiscal Q3 2026 (ended Sep 30, 2026), down 32.6% from a year earlier and up 6.1% from the prior quarter. For the full fiscal 2025 it was $37.06M, down 19.2% from fiscal 2024. Compound annual growth was +11.2% over 5 years. It rose in 3 of the last 5 fiscal years.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
Revenue$241.52M$252.20M$251.41M$222.65M$166.15M$118.32M
Cost of revenue$58.25M$54.73M$47.48M$42.63M--
Gross profit$183.28M$197.47M$203.93M$180.03M$125.47M$87.85M
Research and development$34.78M$36.52M$42.44M$34.89M$18.57M$11.06M
Selling, general and admin$51.63M$49.27M$58.86M$51.56M$32.86M$14.37M
Operating income-$224.27M-$710.82M-$329.80M-$44.04M-$27.32M-$15.89M
Interest expense$11.29M$14.84M$15.20M$11.20M$25.90M$36.49M
Pre-tax income-$209.26M-$633.75M-$308.18M-$41.88M-$62.77M-$52.60M
Income tax-$9.96M-$42.30M-$18.55M-$17.70M-$443.0K$0
Net income-$138.93M-$413.12M-$202.39M-$7.22M-$17.84M$0
EPS, basic-$1.30-$3.54-$1.79-$0.07-$0.19-
EPS, diluted-$1.30-$3.54-$1.79-$0.07-$0.19-
Diluted shares106.7M116.6M112.8M101.1M91.9M-

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
Cash and equivalents$163.63M$105.38M$130.98M$146.93M$387.50M$24.77M
Short-term investments$17.26M$184.79M$177.09M$184.94M$0-
Receivables$51.98M$53.20M$59.25M$58.80M$43.34M$33.11M
Current assets$257.61M$370.17M$393.93M$413.75M$444.23M$63.84M
Goodwill$197.22M$393.28M$1.08B$1.32B$1.26B$1.26B
Total assets$735.49M$1.09B$1.83B$2.12B$2.12B$1.75B
Current liabilities$156.79M$161.16M$170.68M$140.61M$123.12M$91.28M
Short-term debt$8.75M$13.75M$13.75M$8.59M$6.88M$4.68M
Long-term debt$156.09M$229.37M$242.57M$255.76M$263.81M$457.20M
Total debt$164.84M$243.12M$256.32M$264.36M$270.68M$461.88M
Total liabilities$356.50M$482.19M$626.73M$640.68M$617.78M$554.42M
Shareholders' equity$378.99M$607.19M$1.20B$1.48B$1.50B$1.19B

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
Operating cash flow$53.78M$58.20M$41.19M$35.58M$25.21M$23.22M
Capital expenditures$16.72M$12.34M$2.98M$8.33M$6.73M$1.40M
Free cash flow$37.06M$45.85M$38.21M$27.25M$18.48M$21.82M
Investing cash flow$153.88M-$26.41M-$31.78M-$248.90M-$46.73M-$23.86M
Financing cash flow-$150.79M-$56.75M-$25.58M-$26.70M$384.37M$16.66M
Share repurchases$49.45M$22.37M$0$0--
Stock-based compensation$29.14M$38.09M$48.74M$36.43M$9.96M$1.75M
Depreciation and amortization$3.30M$2.25M$1.95M$2.19M$1.75M$1.15M

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
Revenue growth, YoY-4.2%0.3%12.9%34.0%40.4%-
Gross margin75.9%78.3%81.1%80.9%75.5%74.2%
Operating margin-92.9%-281.8%-131.2%-19.8%-16.4%-13.4%
Net margin-57.5%-163.8%-80.5%-3.2%-10.7%0.0%
Free cash flow margin15.3%18.2%15.2%12.2%11.1%18.4%
Return on equity-36.7%-68.0%-16.9%-0.5%-1.2%0.0%
Return on assets-18.9%-37.9%-11.1%-0.3%-0.8%0.0%
Current ratio1.642.302.312.943.610.70
Debt to equity0.430.400.210.180.180.39

Source: XBRL data Definitive Healthcare Corp. files with the SEC, latest filing dated Nov 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

DH peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
DH$227.31M-6.2%-$213.01M-93.7%$163.0M
MSFT$346.44B+17.9%$142.63B41.2%$4.05T
PLTR$7.29B+87.1%$3.67B50.3%$407.69B
ORCL$71.78B+21.6%$18.92B26.4%$362.21B
SAP€36.80B+7.7%€7.16B19.5%$291.67B
CRWD$5.40B+24.3%$58.46M1.1%$234.05B
SHOP$14.17B+32.5%$2.13B15.0%$195.63B
CRM$43.94B+11.2%$9.66B22.0%$176.90B
NOW$15.43B+21.8%$1.45B9.4%$106.66B

DH FAQ

9 questions
  • What is DH revenue?
    Definitive Healthcare Corp. (DH) reported $227.31M of revenue for the twelve months ended Sep 30, 2026. That is down 6.2% from the year before. Revenue for fiscal 2025 was $241.52M.
  • Is DH profitable?
    No. Definitive Healthcare Corp. reported a net loss of $213.01M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does DH have?
    Definitive Healthcare Corp. reported $177.14M in cash and cash equivalents and $158.53M of debt on its most recent balance sheet in SEC filings.
  • How fast is DH revenue growing?
    Definitive Healthcare Corp.'s revenue changed -4.2% in fiscal 2025, to $241.52M. Its compound annual growth rate was +15.3% over 5 years.
  • What is DH gross margin?
    Definitive Healthcare Corp.'s gross profit was $171.33M on $227.31M of revenue for the twelve months ended Sep 30, 2026, a gross margin of 75.4%.
  • What is DH free cash flow?
    Definitive Healthcare Corp. generated $24.19M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $37.16M less capital expenditures.
  • What is DH earnings per share?
    Diluted earnings per share were -$1.55 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did DH last report financial results?
    The latest statements here come from Definitive Healthcare Corp.'s 10-Q filed on Nov 5, 2026, covering the period ended Sep 30, 2026.
  • Where does this DH financial data come from?
    Quantisnow builds these statements from the structured XBRL data Definitive Healthcare Corp. files with the SEC. It is provided for information only and is not investment advice.